Quinoline derivatives and use thereof as antagonists of leukotriene D.sub.4
申请人:Rorer Pharmaceutical Corp.
公开号:US04920133A1
公开(公告)日:1990-04-24
This invention relates to certain quinoline-diaryl compounds and their use as leukotriene D.sub.4 antagonists for the treatment of hypersensitive disorders.